Displaying 1–24 of 24 results for Eric S. Langer, President, BioPlan Associates, Inc

Sort By Relevance Sort By Date

Biopharma CMO Consolidation: Opportunity or Obstacle?

(Article)

Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.

New Technologies for Downstream Efficiencies

(Article)

Industry sees promise in continuous purification

New Technologies for Downstream Efficiencies

(Article)

Industry sees promise in continuous purification

BRIEF: New Technologies for Downstream Efficiencies

(Article)

Industry study indicates Biopharma sees promise in continuous purification

Biopharma's Growing Momentum

(Article)

Gaining both mass and velocity, Biopharma is an industry on the move

Seeking Innovation to Solve Persistent Problems

(Article)

Study reveals biopharma's growing demand for effective technologies to drive efficiency and productivity in and cost out of biopharmaceutical processing

PAT Adoption Hurdles Remain

(Article)

Despite challenges, mainstream adoption is the future

Focus on Efficiency

(Article)

Single-use, analytical methods and downstream processing at the forefront.

Breaking the Biotech Bottleneck

(Article)

Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic”

Biomanufacturing Shows Signs of Maturity, PAT Adoption

(Article)

Manufacturers are reporting fewer batch failures, adopting PAT and other quality initiatives, and stepping up supply chain quality control.

BioManufacturers Do More Supplier Auditing

(Article)

Quality management is part of an increased focus on productivity and performance.

Groundbreakers: Tomorrow's Drug Manufacturing Facilities

(Article)

Modular construction and disposable process equipment are maximizing agility and minimizing risk.

Demand for Innovation: Disposable Devices Top the List in 2011

(Article)

The demand for improvements in single use, disposable bioprocessing equipment have shot to the top of end-users’ wish list of better, more innovative products in 2011

Biopharma Demands Better Analytical Assays

(Article)

Biosimilars and productivity improvements are driving the market.

Biomanufacturing Morphs

(Article)

In biopharma, budgets are returning and manufacturers are emphasizing innovation, productivity, and cost control.

Single-Use Trends Boosting Adoption

(Article)

The latest industry survey shows application trends, and areas where end users would like to see improvement

As Biopharma Matures: Working Harder, Getting Leaner

(Article)

Chronic problems, including downstream costs, disposable equipment issues, and the need for real-time process monitoring, challenge growing manufacturers to keep in shape.

Langer: The Future of Biomanufacturing: Towards More, and Better, Therapies

(Article)

Improvements in biomanufacturing will lead to improvements in most everything that matters to industry and consumers, including more products, more variety, more diseases being treated, and more effective therapies.

What's Holding Back Single-Use Bioprocessing?

(Article)

Disposable equipment can now handle complex bioprocessing, but concerns about cost and leachables and extractables remain key issues.

Biopharma Faces the Future

(Article)

Executives at nearly 450 global drug manufacturers weigh in on what’s troubling them now, and what challenges face them ahead.

Fast Track

Pharma fast track -- 60 second article briefs

Sort By Relevance Sort By Date